BONEHU0123 Stock Overview
BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
BBS-Bioactive Bone Substitutes Oyj Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.0004 |
| 52 Week High | €0.065 |
| 52 Week Low | €0.0002 |
| Beta | -0.084 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -98.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| BONEHU0123 | FI Biotechs | FI Market | |
|---|---|---|---|
| 7D | 100.0% | 1.7% | -0.3% |
| 1Y | n/a | -11.0% | -14.9% |
Return vs Industry: Insufficient data to determine how BONEHU0123 performed against the Finnish Biotechs industry.
Return vs Market: Insufficient data to determine how BONEHU0123 performed against the Finnish Market.
Price Volatility
| BONEHU0123 volatility | |
|---|---|
| BONEHU0123 Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 7.3% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in FI Market | 7.9% |
| 10% least volatile stocks in FI Market | 3.3% |
Stable Share Price: BONEHU0123's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine BONEHU0123's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 22 | Ilkka Kangasniemi | www.bbs-artebone.fi |
BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland. It offers ARTEBONE, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins used primarily for the treatment of bone defects and healing problems in extremities, such as foot and ankle. The company was incorporated in 1991 and is headquartered in Oulu, Finland.
BBS-Bioactive Bone Substitutes Oyj Fundamentals Summary
| BONEHU0123 fundamental statistics | |
|---|---|
| Market cap | €5.55m |
| Earnings (TTM) | -€3.09m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.8x
P/E RatioIs BONEHU0123 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BONEHU0123 income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €29.95k |
| Gross Profit | -€29.95k |
| Other Expenses | €3.06m |
| Earnings | -€3.09m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
Aug 25, 2023
| Earnings per share (EPS) | -0.31 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 132.8% |
How did BONEHU0123 perform over the long term?
See historical performance and comparison